Validation of Dynamic Aspartate‐to–Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality
The dynamic aspartate‐to–alanine aminotransferase ratio (dAAR) was developed recently to predict the risk of incident chronic liver disease among the Nordic adult population; however, the dAAR has not been externally validated in other ethnic cohorts. Therefore, we aimed to examine the predictive ab...
Main Authors: | In‐Ae Song, Eun Sun Jang, Tak Kyu Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-04-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1844 |
Similar Items
-
A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
by: Fredrik Åberg, et al.
Published: (2021-06-01) -
Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
by: Daiki Kobayashi, et al.
Published: (2022-02-01) -
Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure
by: Daichi Maeda, et al.
Published: (2021-06-01) -
Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma
by: Johann von Felden, et al.
Published: (2020-09-01) -
Comparison of the Ornithine Carbamyltransferase with Aspartate Aminotransferase and Alanine Aminotransferase in patients with liver diseases
by: HR.Joshaghani, et al.
Published: (2002-09-01)